FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061196 [Registered on: 08/01/2024] Trial Registered Prospectively
Last Modified On: 27/12/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Platelet rich Plasma ]  
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Enhancing Scars with Platelet Rich Plasma: A Healthier Look 
Scientific Title of Study   Efficacy of Platelet rich plasma in reducing the scar width of primary cleft lip repair; a double-blinded randomized control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sreepriya PP 
Designation  Academic Senior Resident Mch Burns and plastic surgery  
Affiliation  All India Institute of Medical Science Pata 
Address  Academic Senior Resident Department of Burns and PLastic Surgery All India Institute of Medical Scienses Phulwarisharif Ppatna Bihar

Patna
BIHAR
801507
India 
Phone  9847665571  
Fax    
Email  sreepriyapp94@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Veena K Singh  
Designation  Additional Professor 
Affiliation  All India Institute of Medical Sciences Pata 
Address  Additional Professor and Head of the department Burns and Plastic Surgery All India Institute of Medical Sciences Phulwarisharif Patna Bihar

Patna
BIHAR
801507
India 
Phone  9905755111  
Fax    
Email  drsveena@aiimspatna.org  
 
Details of Contact Person
Public Query
 
Name  Dr Ansarul Haq 
Designation  Associate Professor 
Affiliation  All India Institute of Medical Sciences Pata 
Address  Associate Professor Department Burns and Plastic Surgery All India Institute of Medical Sciences Phulwarisharif Patna Bihar

Patna
BIHAR
801507
India 
Phone  9897216325  
Fax    
Email  dransarulhaq@aiimspatna.org  
 
Source of Monetary or Material Support  
All India Institute Of Medical Sciences Patna  
 
Primary Sponsor  
Name  All India Institute of Medical sciences 
Address  Phulwarisharif, Patna 801507 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sreepriya PP  All India Institute of Medical Sciences, Patna  Room 543, Department of Burns and Plastic surgery
Patna
BIHAR 
9847665571

sreepriyapp94@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Q369||Cleft lip, unilateral,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Normal Saline   2- 6 month old age group intra opertative administration of saline over suture line 
Intervention  Platelet rich plasma  2- 6 month old age group intra opertative administration of platelet rich plasma over suture line Dose 0.25 ml 1st during muscle layer closure then during skin layer closure 
 
Inclusion Criteria  
Age From  2.00 Month(s)
Age To  6.00 Month(s)
Gender  Both 
Details  i) Non-syndromic complete unilateral cleft lip
ii) American Society of Anesthesiologists (ASA) grade 1 and 2
iii) Consenting to participate
iv) Not a part of any other trial or research project
 
 
ExclusionCriteria 
Details  i) Syndromic patients
ii) Very wide cleft lip
iii) Children with neuromuscular disorders
iv) Not willing for consent
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Scar width of lip repair clinically and with ultrasound in mm in intervention group and control   6 months 
 
Secondary Outcome  
Outcome  TimePoints 
1) To evaluate the scar quality based on the Vancouver scar scale
2) To determine Incidence of Surgical site infection (SSI)
 
6 months 
 
Target Sample Size   Total Sample Size="32"
Sample Size from India="32" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="20" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title of the proposal

 Efficacy of Platelet rich plasma in reducing the scar width of primary cleft lip repair; a double-blinded randomized control trial

Introduction

Unavoidable visible cheiloplasty scars remain the main topic searched by cleft surgeons1. Platelet-rich plasma helps to regenerate injured tissues and improve scar appearance, as it is rich in various cytokines and growth factors that promote tissue remodeling, angiogenesis, and healing2.

Various studies have reported that PRP acts as an effective therapy for muscle injury, chronic wounds, and atrophic and contractile scars by rejuvenating skin tissue and texture3.

Novelty of our study is that only single study in literature that have prospectively assessed the impact of Platelet-rich plasma on post-surgical cleft lip repair scar till now.

Review of Literature

Cleft lip and palate are the most common congenital conditions affecting the pediatric group5. They affect the child’s appearance, causing psychological and social encumbrance6. Unavoidable visible cheiloplasty scars remain the main topic searched by cleft surgeons. Platelet-rich plasma (PRP) is a concentrate of autologous platelets and plasma that has recently contributed to many fields, such as plastic surgical, orthopaedic, and dental research. Platelet-rich plasma helps to regenerate injured tissues and improve scar appearance, as it is rich in various cytokines and growth factors (GFs) that promote tissue remodelling, angiogenesis, and healing.3

 

Refahee et al4 in did and RCT with sample size of 24 with 12 in each arms to look for the effect of PRP in better scar after cleft lip repair, and found that mean scar width by ultrasound at 6 months was 4.96 + 0.929 and 3.8 + 0.886 mm in the control and study groups, respectively. According to photographic measurements, the scar was significantly narrower at both the first point (0.831 +/- 0.231 mm vs 1.49 +/- 0.442 mm, and the second point (1.015 +/- 0.103 mm vs 2.275 +/- 0.984.

Martinez-Zapata MJ et al5 in his systematic review of Autologous platelet-rich plasma for treating chronic wounds, which included 10 RCTs found that the proportion of completely healed chronic wounds was reported in seven RCTs that compared PRP with standard treatment or placebo, with no statistically significant difference between the groups, in diabetic foot ulcers (RR 1.16; 95% CI 0.57 to 2.35), in venous leg ulcers (pooled RR 1.02; 95% CI 0.81 to 1.27; I2=0% ) and in mixed chronic wounds (pooled RR 1.85; 95% CI 0.76 to 4.51; I2=42%). The percentage of wound area healed was reported in two RCTs of mixed chronic wounds, and results were statistically significant in favour of the PRP group (RR 51.78%; 95% CI 32.70 to 70.86; I2= 0%).

In retrospective cohort study by Wen-Hao Zhang et6 al found patients of unilateral cleft lip, the upper lip orbicularis oris muscle was scanned using ultrasound in natural closure and pout states. After reconstruction of the unilateral cleft lip, the left and right philtrum columns were still obviously asymmetric, their radian displayed clearly and showed better continuity. So, ultrasound imaging is able to clearly show the hierarchical structure of upper lip orbicularis oris muscle, and will be beneficial in guiding the upper lip repair and reconstruction surgery.

Methodology

Study design: Double-blinded randomized controlled trial with Allocation concealment, operating surgeon and follow up surgeon will be blinded.

Study participants: Patients accepted for randomization with a non-syndromic complete unilateral cleft lip with or without cleft palate and will be planned for repair at 2 to 6 months of age we , excluded syndromic patients, child with very wide cleft lip, children with neuromuscular disorder

We defined our study and control group as, patients with unilateral cleft lip were treated with the modified Millard technique/ Tennison Randal and PRP injection intraoperatively and patients with unilateral cleft lip were treated with the modified Millard technique / Tennison Randal with placebo respectively.

Aim of our study: To compare the efficacy of Platelet rich plasma in Reducing the Scar Width of Primary Cleft Lip Repair with a placebo.

Primary objective: To compare the scar width clinically and with ultrasound in mm in two groups.

Secondary objectives: To evaluate the scar quality based on the Vancouver scar scale, to determine Incidence of Surgical site infection.

We calculated sample size based on the randomized controlled trial carried out by Refahee et al4, The mean scar width by ultrasound at 6 months was 4.96+/-0.929 and 3.8 +/- 0.886 mm in the control and study groups respectively. Assuming a true difference in mean scar width 1.16 units, a pooled standard deviation of 0. 90 units, the study would require a sample size of: 13 for each group, to achieve a power of 90% and a level of significance of 5%. Further, assuming a drop-out rate of 20 % from the study, the final sample size comes out to be, 33 with 16 patients in each arm.

Study procedure:

Patients will be prepared as per our institutional protocol. Modified Millard technique or Tennison Randal repair will be performed in a 3-layer closure of the mucosa, muscle, and skin.

In study group PRP will be prepared from 10 mL of the patient’s own blood under completely sterile conditions at the time of surgery. Following muscle closure, approximately 0.25 mL of PRP will be injected on each side along the suture line of the muscle layer and another 0.25 mL of PRP will be injected on each side along the suture line of the dermis layer. Postoperative Period and Follow-Up will be followed as per our institutional protocol.

The width of the scar will be assessed at 6 months postoperatively via ultrasound (7.5-9MHz) and over the skin via photography.

The scar width will be measured at 3 different points with Photoshop (CS5 extended version 12.0; Adobe Systems Inc, San Jose, California) using the ruler as a control reference.

If it can be proved that there is better outcome in terms of scar post-operatively with it may help to modify our institutional practice of cleft lip repair.

References:

1)     Hunt O, Burden D, Hepper P, Johnston C. The psychosocial effects of cleft lip and palate: a systematic review. Eur J Orthodont. 2005;27(3):274-285

2)     McAleer JP, Sharma S, Kaplan EM, Persich G. Use of autologous platelet concentrate in a nonhealing lower extremity wound. Adv Skin Wound Care. 2006;19(7):354-363

3)     Nita A, Orzan O, Filipescu M, Jianu D. Fat graft, laser CO2 and platelet-rich-plasma synergy in scars treatment. J Med Life. 2013;6(4):430

4)     Refahee SM, Aboulhassan MA, Abdel Aziz O, Emara D, Seif El Dein HM, Moussa BG, Abu Sneineh M. Is PRP Effective in Reducing the Scar Width of Primary Cleft Lip Repair? A Randomized Controlled Clinical Study. Cleft Palate Craniofac J. 2020 May;57(5):581-588. doi: 10.1177/1055665619884455. Epub 2019 Oct 30. PMID: 31665898.

5)     Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Expósito JA, Bolíbar I, Rodríguez L, Garcia J. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev. 2012 Oct 17;10:CD006899. doi: 10.1002/14651858.CD006899.pub2. Update in: Cochrane Database Syst Rev. 2016;(5):CD006899. PMID: 23076929

6)     Zhang WH, Chen YY, Liu JJ, Liao XH, Du YC, Gao Y. Application of ultrasound imaging of upper lip orbicularis oris muscle. Int J Clin Exp Med. 2015 Mar 15;8(3):3391-400. PMID: 26064229; PMCID: PMC4443063

 
Close